Clinical Trials Directory

Trials / Completed

CompletedNCT04642989

The Effect of Facial Effleurage on Acute Rhinosinusitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
138 (actual)
Sponsor
Edward Via Virginia College of Osteopathic Medicine · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

Rhinosinusitis accounts for 12% of the total antibiotic prescriptions filled in the United States annually; however, the majority of rhinosinusitis cases have been proposed to have a viral etiology, or are capable of spontaneously resolving. This overuse of antibiotics is contributing to the development of antibiotic-resistant human pathogenic bacteria, and increasing patient mortality to previously easily cured diseases. This is also causing an unnecessary financial burden especially for uninsured, rural families. Facial Effleurage (FE) is an osteopathic manipulative therapy that allows physicians an alternative therapy to prescribing antibiotics; however, the only scientific literature on the technique is weak in design and execution. This will be a randomized, placebo-controlled clinical trial to test the ability of FE to reduce symptom severity over time, reduce the cellular infiltrate into the nasal cavity, and to more quickly resolve the symptoms of rhinosinusitis compared to antibiotic treatment. This methodical approach to the efficacy of FE has the potential to impact the treatment recommendations of physicians immediately, and to convince more physicians to prescribe less antibiotics and rely more heavily on FE.

Conditions

Interventions

TypeNameDescription
OTHERSham TreatmentAll movements of facial effleurage except applying pressure
OTHERFacial EffleurageFacial massage to remove any lymphatic blockages
DRUGAntibioticsAppropriate "standard-of-care" antibiotics as determined by the physician.

Timeline

Start date
2018-09-01
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2020-11-24
Last updated
2020-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04642989. Inclusion in this directory is not an endorsement.